About this Journal Submit a Manuscript Table of Contents
Evidence-Based Complementary and Alternative Medicine
Volume 2012 (2012), Article ID 294058, 14 pages
http://dx.doi.org/10.1155/2012/294058
Research Article

The Effects of a Gentle Yoga Program on Sleep, Mood, and Blood Pressure in Older Women with Restless Legs Syndrome (RLS): A Preliminary Randomized Controlled Trial

1Department of Community Medicine, West Virginia University School of Medicine, P.O. Box 9190, Morgantown, WV 26506-9190, USA
2Center for the Study of Complementary and Alternative Therapies, University of Virginia Health System, P.O. Box 800782, McLeod Hall, Charlottesville, VA 22908-0782, USA

Received 21 November 2011; Accepted 21 December 2011

Academic Editor: David Mischoulon

Copyright © 2012 Kim E. Innes and Terry Kit Selfe. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. K. E. Innes, T. K. Selfe, and P. Agarwal, “Prevalence of restless legs syndrome in North American and Western European populations: a systematic review,” Sleep Medicine, vol. 12, no. 7, pp. 623–634, 2011. View at Publisher · View at Google Scholar
  2. R. P. Allen, D. Picchietti, W. A. Hening et al., “Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health,” Sleep Medicine, vol. 4, no. 2, pp. 101–119, 2003. View at Publisher · View at Google Scholar · View at Scopus
  3. L. Abetz, R. Allen, A. Follet et al., “Evaluating the quality of life of patients with restless legs syndrome,” Clinical Therapeutics, vol. 26, no. 6, pp. 925–935, 2004. View at Publisher · View at Google Scholar · View at Scopus
  4. J. P. Reese, K. Stiasny-Kolster, W. H. Oertel, and R. C. Dodel, “Health-related quality of life and economic burden in patients with restless legs syndrome,” Expert Review of Pharmacoeconomics and Outcomes Research, vol. 7, no. 5, pp. 503–521, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. T. Reinhold, F. Mller-Riemenschneider, S. N. Willich, and B. Brggenjrgen, “Economic and human costs of restless legs syndrome,” PharmacoEconomics, vol. 27, no. 4, pp. 267–279, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. S. Happe, J. P. Reese, K. Stiasny-Kolster et al., “Assessing health-related quality of life in patients with restless legs syndrome,” Sleep Medicine, vol. 10, no. 3, pp. 295–305, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. C. J. Earley and M. H. Silber, “Restless legs syndrome: understanding its consequences and the need for better treatment,” Sleep Medicine, vol. 11, no. 9, pp. 807–815, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. J. W. Winkelman, “Considering the causes of RLS,” European Journal of Neurology, vol. 13, no. 2, pp. 8–14, 2006. View at Publisher · View at Google Scholar · View at Scopus
  9. A. S. Walters and D. B. Rye, “Review of the relationship of restless legs syndrome and periodic limb movements in sleep to hypertension, heart disease, and stroke,” Sleep, vol. 32, no. 5, pp. 589–597, 2009. View at Scopus
  10. J. E. Smith and J. M. Tolson, “Recognition, diagnosis, and treatment of restless legs syndrome,” Journal of the American Academy of Nurse Practitioners, vol. 20, no. 8, pp. 396–401, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. W. B. Matthews, “Letter: iron deficiency and restless legs,” British Medical Journal, vol. 1, no. 6014, p. 898, 1976. View at Scopus
  12. R. Sandyk, “The restless legs syndrome (Ekbom's syndrome),” South African Medical Journal, vol. 63, no. 18, pp. 701–702, 1983. View at Scopus
  13. S. T. O'Keeffe, “Restless legs syndrome: a review,” Archives of Internal Medicine, vol. 156, no. 3, pp. 243–248, 1996. View at Publisher · View at Google Scholar · View at Scopus
  14. R. Allen, “Dopamine and iron in the pathophysiology of restless legs syndrome (RLS),” Sleep Medicine, vol. 5, no. 4, pp. 385–391, 2004. View at Publisher · View at Google Scholar · View at Scopus
  15. L. M. Trotti, S. Bhadriraju, and D. B. Rye, “An update on the pathophysiology and genetics of restless legs syndrome,” Current Neurology and Neuroscience Reports, vol. 8, no. 4, pp. 281–287, 2008. View at Publisher · View at Google Scholar · View at Scopus
  16. K. Ekbom and J. Ulfberg, “Restless legs syndrome,” Journal of Internal Medicine, vol. 266, no. 5, pp. 419–431, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. C. Trenkwalder, B. Högl, and J. Winkelmann, “Recent advances in the diagnosis, genetics and treatment of restless legs syndrome,” Journal of Neurology, vol. 256, no. 4, pp. 539–553, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. C. Trenkwalder and W. Paulus, “Restless legs syndrome: pathophysiology, clinical presentation and management,” Nature Reviews Neurology, vol. 6, no. 6, pp. 337–346, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. C. J. Earley, R. P. Allen, J. R. Connor, L. Ferrucci, and J. Troncoso, “The dopaminergic neurons of the A11 system in RLS autopsy brains appear normal,” Sleep Medicine, vol. 10, no. 10, pp. 1155–1157, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. B. McDonagh, T. King, and R. C. Guptan, “Restless legs syndrome in patients with chronic venous disorders: an untold story,” Phlebology, vol. 22, no. 4, pp. 156–163, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. K. E. Innes, T. K. Selfe, and P. Agarwal, “Restless legs syndrome and conditions associated with metabolic dysregulation, sympathoadrenal dysfunction, and cardiovascular disease risk: a systematic review,” Sleep Medicine Reviews, vol. 38, no. 5, pp. 1–31, 2011. View at Publisher · View at Google Scholar
  22. R. Ferri, M. Zucconi, F. Rundo, K. Spruyt, M. Manconi, and L. Ferini-Strambi, “Heart rate and spectral EEG changes accompanying periodic and non-periodic leg movements during sleep,” Clinical Neurophysiology, vol. 118, no. 2, pp. 438–448, 2007. View at Publisher · View at Google Scholar · View at Scopus
  23. F. Siddiqui, J. Strus, X. Ming, I. A. Lee, S. Chokroverty, and A. S. Walters, “Rise of blood pressure with periodic limb movements in sleep and wakefulness,” Clinical Neurophysiology, vol. 118, no. 9, pp. 1923–1930, 2007. View at Publisher · View at Google Scholar · View at Scopus
  24. M. H. Pennestri, J. Montplaisir, R. Colombo, G. Lavigne, and P. A. Lanfranchi, “Nocturnal blood pressure changes in patients with restless legs syndrome,” Neurology, vol. 68, no. 15, pp. 1213–1218, 2007. View at Publisher · View at Google Scholar · View at Scopus
  25. C. Schilling, M. Schredl, P. Strobl, and M. Deuschle, “Restless legs syndrome: evidence for nocturnal hypothalamic-pituitary- adrenal system activation,” Movement Disorders, vol. 25, no. 8, pp. 1047–1052, 2010. View at Publisher · View at Google Scholar · View at Scopus
  26. M. A. Cikrikcioglu, M. Hursitoglu, H. Erkal et al., “Oxidative stress and autonomic nervous system functions in restless legs syndrome,” European Journal of Clinical Investigation, vol. 41, no. 7, pp. 734–742, 2011. View at Publisher · View at Google Scholar
  27. L. Ferrin-Strambi, F. Poccia, A. Oldani, et al., “Heart rate variability during wakefulness and sleep in restless legs,” Syndrome Journal of Sleep Research, vol. 9, article 63, 2000.
  28. W. H. Oertel, C. Trenkwalder, M. Zucconi et al., “State of the art in restless legs syndrome therapy: practice recommendations for treating restless legs syndrome,” Movement Disorders, vol. 22, supplement 18, pp. S466–S475, 2007. View at Publisher · View at Google Scholar · View at Scopus
  29. K. Spiegelhalder and M. Hornyak, “Restless legs syndrome in older adults,” Clinics in Geriatric Medicine, vol. 24, no. 1, pp. 167–180, 2008. View at Publisher · View at Google Scholar · View at Scopus
  30. C. Trenkwalder, W. A. Hening, P. Montagna et al., “Treatment of restless legs syndrome: an evidence-based review and implications for clinical practice,” Movement Disorders, vol. 23, no. 16, pp. 2267–2302, 2008. View at Publisher · View at Google Scholar · View at Scopus
  31. D. García-Borreguero and A. M. Williams, “Dopaminergic augmentation of restless legs syndrome,” Sleep Medicine Reviews, vol. 14, no. 5, pp. 339–346, 2010. View at Publisher · View at Google Scholar · View at Scopus
  32. S. A. Milligan and A. L. Chesson, “Restless legs syndrome in the older adult: diagnosis and management,” Drugs and Aging, vol. 19, no. 10, pp. 741–751, 2002. View at Scopus
  33. N. Wolkove, O. Elkholy, M. Baltzan, and M. Palayew, “Sleep and aging: 2. Management of sleep disorders in older people,” CMAJ, vol. 176, no. 10, pp. 1449–1454, 2007. View at Publisher · View at Google Scholar · View at Scopus
  34. V. Cochen, C. Arbus, M. E. Soto et al., “Sleep disorders and their impacts on healthy, dependent, and frail older adults,” Journal of Nutrition, Health and Aging, vol. 13, no. 4, pp. 322–329, 2009. View at Publisher · View at Google Scholar · View at Scopus
  35. J. W. Winkelman and L. Johnston, “Augmentation and tolerance with long-term pramipexole treatment of restless legs syndrome (RLS),” Sleep Medicine, vol. 5, no. 1, pp. 9–14, 2004. View at Publisher · View at Google Scholar · View at Scopus
  36. D. Garcia-Borreguero, R. Allen, R. Kohnen et al., “Loss of response during long-term treatment of restless legs syndrome: guidelines approved by the International Restless Legs Syndrome Study Group for use in clinical trials,” Sleep Medicine, vol. 11, no. 9, pp. 956–957, 2010. View at Publisher · View at Google Scholar · View at Scopus
  37. G. K. Sakkas, G. M. Hadjigeorgiou, C. Karatzaferi et al., “Intradialytic aerobic exercise training ameliorates symptoms of restless legs syndrome and improves functional capacity in patients on hemodialysis: a pilot study,” ASAIO Journal, vol. 54, no. 2, pp. 185–190, 2008. View at Publisher · View at Google Scholar
  38. M. M. Aukerman, D. Aukerman, M. Bayard, F. Tudiver, L. Thorp, and B. Bailey, “Exercise and restless legs syndrome: a randomized controlled trial,” Journal of the American Board of Family Medicine, vol. 19, no. 5, pp. 487–493, 2006. View at Scopus
  39. M. Hornyak, C. Grossmann, R. Kohnen et al., “Cognitive behavioural group therapy to improve patients' strategies for coping with restless legs syndrome: a proof-of-concept trial,” Journal of Neurology, Neurosurgery and Psychiatry, vol. 79, no. 7, pp. 823–825, 2008. View at Publisher · View at Google Scholar
  40. P. M. Barnes, B. Bloom, and R. L. Nahin, “Complementary and alternative medicine use among adults and children: United States, 2007,” National Health Statistics Reports, no. 12, pp. 1–23, 2009. View at Scopus
  41. K. Yang, “A review of yoga programs for four leading risk factors of chronic diseases,” Evidence-Based Complementary and Alternative Medicine, vol. 4, no. 4, pp. 487–491, 2007. View at Publisher · View at Google Scholar · View at Scopus
  42. K. E. Innes and H. K. Vincent, “The influence of yoga-based programs on risk profiles in adults with type 2 diabetes mellitus: a systematic review,” Evidence-Based Complementary and Alternative Medicine, vol. 4, no. 4, pp. 469–486, 2007. View at Publisher · View at Google Scholar · View at Scopus
  43. L. A. Gordon, E. Y. Morrison, D. A. McGrowder et al., “Effect of exercise therapy on lipid profile and oxidative stress indicators in patients with type 2 diabetes,” BMC Complementary and Alternative Medicine, vol. 8, article 21, 2008. View at Publisher · View at Google Scholar · View at Scopus
  44. A. Ross and S. Thomas, “The health benefits of yoga and exercise: a review of comparison studies,” Journal of Alternative and Complementary Medicine, vol. 16, no. 1, pp. 3–12, 2010. View at Publisher · View at Google Scholar · View at Scopus
  45. K. E. Innes, T. K. Selfe, and A. G. Taylor, “Menopause, the metabolic syndrome, and mind-body therapies,” Menopause, vol. 15, no. 5, pp. 1005–1013, 2008. View at Publisher · View at Google Scholar · View at Scopus
  46. S. B. S. Khalsa, S. M. Shorter, S. Cope, G. Wyshak, and E. Sklar, “Yoga ameliorates performance anxiety and mood disturbance in young professional musicians,” Applied Psychophysiology Biofeedback, vol. 34, no. 4, pp. 279–289, 2009. View at Publisher · View at Google Scholar · View at Scopus
  47. L. D. Butler, L. C. Waelde, T. A. Hastings et al., “Meditation with yoga, group therapy with hypnosis, and psychoeducation for long-term depressed mood: a randomized pilot trial,” Journal of Clinical Psychology, vol. 64, no. 7, pp. 806–820, 2008. View at Publisher · View at Google Scholar · View at Scopus
  48. K. M. Chen, M. H. Chen, M. H. Lin, J. T. Fan, H. S. Lin, and C. H. Li, “Effects of yoga on sleep quality and depression in elders in assisted living facilities,” The Journal of Nursing Research, vol. 18, no. 1, pp. 53–61, 2010. View at Scopus
  49. K. E. Innes, T. K. Selfe, and A. Vishnu, “Mind-body therapies for menopausal symptoms: a systematic review,” Maturitas, vol. 66, no. 2, pp. 135–149, 2010. View at Publisher · View at Google Scholar · View at Scopus
  50. K. M. Chen, M. H. Chen, H. C. Chao, H. M. Hung, H. S. Lin, and C. H. Li, “Sleep quality, depression state, and health status of older adults after silver yoga exercises: cluster randomized trial,” International Journal of Nursing Studies, vol. 46, no. 2, pp. 154–163, 2009. View at Scopus
  51. M. Yurtkuran, A. Alp, M. Yurtkuran, and K. Dilek, “A modified yoga-based exercise program in hemodialysis patients: a randomized controlled study,” Complementary Therapies in Medicine, vol. 15, no. 3, pp. 164–171, 2007. View at Publisher · View at Google Scholar · View at Scopus
  52. O. P. Bhatnagar and V. Anantharaman, “The effect of Yoga training on neuromuscular excitability and muscular relaxation,” Neurology India, vol. 25, no. 4, pp. 230–232, 1977. View at Scopus
  53. F. Tergau, S. Wischer, and W. Paulus, “Motor system excitability in patients with restless legs syndrome,” Neurology, vol. 52, no. 5, pp. 1060–1063, 1999. View at Scopus
  54. A. Scalise, I. Pittaro-Cadore, F. Janes, R. Marinig, and G. L. Gigli, “Changes of cortical excitability after dopaminergic treatment in restless legs syndrome,” Sleep Medicine, vol. 11, no. 1, pp. 75–81, 2010. View at Publisher · View at Google Scholar · View at Scopus
  55. K. R. Chaudhuri, “The restless legs syndrome: time to recognize a very common movement disorder,” Practical Neurology, vol. 3, no. 4, pp. 204–213, 2003. View at Scopus
  56. D. MacMahon, S. Muzerengi, and K. R. Chaudhuri, “Treatment and identification of restless legs syndrome,” Prescriber, vol. 5, pp. 56–59, 2008.
  57. K. E. Innes, T. K. Selfe, G. K. Alexander, and A. G. Taylor, “A new educational film control for use in studies of active mind-body therapies: acceptability and feasibility,” Journal of Alternative and Complementary Medicine, vol. 17, no. 5, pp. 453–458, 2011. View at Publisher · View at Google Scholar
  58. D. J. Buysse, C. F. Reynolds, T. H. Monk, S. R. Berman, and D. J. Kupfer, “The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research,” Psychiatry Research, vol. 28, no. 2, pp. 193–213, 1989. View at Scopus
  59. S. Cohen, T. Kamarck, and R. Mermelstein, “A global measure of perceived stress,” Journal of Health and Social Behavior, vol. 24, no. 4, pp. 385–396, 1983. View at Scopus
  60. B. G. Berger and R. W. Motl, “Exercise and mood: a selective review and synthesis of research employing the Profile of Mood States,” Journal of Applied Sport Psychology, vol. 12, no. 1, pp. 69–92, 2000.
  61. N. V. Ramanaiah, M. Franzen, and T. Schill, “A psychometric study of the State-Trait Anxiety Inventory,” Journal of Personality Assessment, vol. 47, no. 5, pp. 531–535, 1983. View at Scopus
  62. J. Backhaus, K. Junghanns, A. Broocks, D. Riemann, and F. Hohagen, “Test-retest reliability and validity of the Pittsburgh Sleep Quality Index in primary insomnia,” Journal of Psychosomatic Research, vol. 53, no. 3, pp. 737–740, 2002. View at Publisher · View at Google Scholar · View at Scopus
  63. D. Picchietti and J. W. Winkelman, “Restless legs syndrome, periodic limb movements in sleep, and depression,” Sleep, vol. 28, no. 7, pp. 891–898, 2005. View at Scopus
  64. A. Ströhle, “Physical activity, exercise, depression and anxiety disorders,” Journal of Neural Transmission, vol. 116, no. 6, pp. 777–784, 2009. View at Publisher · View at Google Scholar · View at Scopus
  65. R. A. Washburn, E. McAuley, J. Katula, S. L. Mihalko, and R. A. Boileau, “The physical activity scale for the elderly (PASE): evidence for validity,” Journal of Clinical Epidemiology, vol. 52, no. 7, pp. 643–651, 1999. View at Publisher · View at Google Scholar · View at Scopus
  66. H. G. Koenig, R. E. Westlund, L. K. George, D. C. Hughes, D. G. Blazer, and C. Hybels, “Abbreviating the Duke Social Support Index for use in chronically ill elderly individuals,” Psychosomatics, vol. 34, no. 1, pp. 61–69, 1993. View at Scopus
  67. J. Cohen, Statistical Power Analysis for the Behavioral Sciences, Lawrence Erlbaum Associates, Hillsdale,, NJ, USA, 2nd edition, 1988.
  68. D. L. Cohen, L. T. Bloedon, R. L. Rothman et al., “Iyengar yoga versus enhanced usual care on blood pressure in patients with prehypertension to stage i hypertension: a randomized controlled trial,” Evidence-based Complementary and Alternative Medicine, vol. 2011, Article ID 546428, 8 pages, 2011. View at Publisher · View at Google Scholar
  69. K. E. Innes, C. Bourguignon, and A. G. Taylor, “Risk indices associated with the insulin resistance syndrome, cardiovascular disease, and possible protection with yoga: a systematic review,” Journal of the American Board of Family Practice, vol. 18, no. 6, pp. 491–519, 2005. View at Scopus
  70. L. G. Saptharishi, M. B. Soudarssanane, D. Thiruselvakumar et al., “Community-based randomized controlled trial of non-pharmacological interventions in prevention and control of hypertension among young adults,” Indian Journal of Community Medicine, vol. 34, no. 4, pp. 329–334, 2009. View at Publisher · View at Google Scholar · View at Scopus
  71. M. Saletu, P. Anderer, B. Högl et al., “Acute double-blind, placebo-controlled sleep laboratory and clinical follow-up studies with a combination treatment of rr-L-dopa and sr-L-dopa in restless legs syndrome,” Journal of Neural Transmission, vol. 110, no. 6, pp. 611–626, 2003. View at Publisher · View at Google Scholar · View at Scopus
  72. Y. Inoue, K. Kuroda, K. Hirata, N. Uchimura, T. Kagimura, and T. Shimizu, “Long-term open-label study of pramipexole in patients with primary restless legs syndrome,” Journal of the Neurological Sciences, vol. 294, no. 1-2, pp. 62–66, 2010. View at Publisher · View at Google Scholar · View at Scopus
  73. S. Happe, G. Klösch, B. Saletu, and J. Zeitlhofer, “Treatment of idiopathic restless legs syndrome (RLS) with gabapentin,” Neurology, vol. 57, no. 9, pp. 1717–1719, 2001. View at Scopus
  74. R. K. Bogan, J. M. Fry, M. H. Schmidt, S. W. Carson, and S. Y. Ritchie, “Ropinirole in the treatment of patients with restless legs syndrome: a US-based randomized, double-blind, placebo-controlled clinical trial,” Mayo Clinic Proceedings, vol. 81, no. 1, pp. 17–27, 2006. View at Scopus
  75. M. Partinen, K. Hirvonen, L. Jama et al., “Efficacy and safety of pramipexole in idiopathic restless legs syndrome: a polysomnographic dose-finding study-The PRELUDE study,” Sleep Medicine, vol. 7, no. 5, pp. 407–417, 2006. View at Publisher · View at Google Scholar · View at Scopus
  76. P. L. McCormack and M. A. A. Siddiqui, “Pramipexole: in restless legs syndrome,” CNS Drugs, vol. 21, no. 5, pp. 429–440, 2007. View at Publisher · View at Google Scholar · View at Scopus
  77. D. Garcia-Borreguero, O. Larrosa, Y. De la Llave, K. Verger, X. Masramon, and G. Hernandez, “Treatment of restless legs syndrome with gabapentin: a double-blind, cross-over study,” Neurology, vol. 59, no. 10, pp. 1573–1579, 2002. View at Scopus
  78. F. Tison, A. Crochard, D. Léger, S. Bouée, E. Lainey, and A. El Hasnaoui, “Epidemiology of restless legs syndrome in French adults—a nationwide survey: the INSTANT Study,” Neurology, vol. 65, no. 2, pp. 239–246, 2005. View at Publisher · View at Google Scholar · View at Scopus
  79. R. P. Allen, A. S. Walters, J. Montplaisir et al., “Restless legs syndrome prevalence and impact: REST general population study,” Archives of Internal Medicine, vol. 165, no. 11, pp. 1286–1292, 2005. View at Publisher · View at Google Scholar · View at Scopus
  80. R. P. Allen, P. Stillman, and A. J. Myers, “Physician-diagnosed restless legs syndrome in a large sample of primary medical care patients in western Europe: prevalence and characteristics,” Sleep Medicine, vol. 11, no. 1, pp. 31–37, 2010. View at Publisher · View at Google Scholar · View at Scopus
  81. K. Berger, J. Luedemann, C. Trenkwalder, U. John, and C. Kessler, “Sex and the risk of restless legs syndrome in the general population,” Archives of Internal Medicine, vol. 164, no. 2, pp. 196–202, 2004. View at Publisher · View at Google Scholar · View at Scopus
  82. H. B. Lee, W. A. Hening, R. P. Allen, C. J. Earley, W. W. Eaton, and C. G. Lyketsos, “Race and restless legs syndrome symptoms in an adult community sample in east Baltimore,” Sleep Medicine, vol. 7, no. 8, pp. 642–645, 2006. View at Publisher · View at Google Scholar · View at Scopus
  83. J. W. Winkelman, L. Finn, and T. Young, “Prevalence and correlates of restless legs syndrome symptoms in the Wisconsin Sleep Cohort,” Sleep Medicine, vol. 7, no. 7, pp. 545–552, 2006. View at Publisher · View at Google Scholar · View at Scopus
  84. H. Hachul, L. R. A. Bittencourt, M. L. Andersen, M. A. Haidar, E. C. Baracat, and S. Tufik, “Effects of hormone therapy with estrogen and/or progesterone on sleep pattern in postmenopausal women,” International Journal of Gynecology and Obstetrics, vol. 103, no. 3, pp. 207–212, 2008. View at Publisher · View at Google Scholar · View at Scopus
  85. P. Polo-Kantola and R. Erkkola, “Sleep and the menopause,” Journal of the British Menopause Society, vol. 10, no. 4, pp. 145–150, 2004. View at Publisher · View at Google Scholar · View at Scopus
  86. G. Saletu-Zyhlarz, P. Anderer, G. Gruber et al., “Insomnia related to postmenopausal syndrome and hormone replacement therapy: sleep laboratory studies on baseline differences between patients and controls and double-blind, placebo-controlled investigations on the effects of a novel estrogen-progestogen combination (Climodien, Lafamme) versus estrogen alone,” Journal of Sleep Research, vol. 12, no. 3, pp. 239–254, 2003. View at Publisher · View at Google Scholar · View at Scopus
  87. G. Weitz, M. Elam, J. Born, H. L. Fehm, and C. Dodt, “Postmenopausal estrogen administration suppresses muscle sympathetic nerve activity,” Journal of Clinical Endocrinology and Metabolism, vol. 86, no. 1, pp. 344–348, 2001. View at Publisher · View at Google Scholar · View at Scopus
  88. A. J. Rothdach, C. Trenkwalder, J. Haberstock, U. Keil, and K. Berger, “Prevalence and risk factors of RLS in an elderly population: the MEMO study,” Neurology, vol. 54, no. 5, pp. 1064–1068, 2000.
  89. J. Wesström, S. Nilsson, I. Sundström-Poromaa, and J. Ulfberg, “Restless legs syndrome among women: prevalence, co-morbidity and possible relationship to menopause,” Climacteric, vol. 11, no. 5, pp. 422–428, 2008. View at Publisher · View at Google Scholar · View at Scopus
  90. I. Ghorayeb, B. Bioulac, C. Scribans, and F. Tison, “Perceived severity of restless legs syndrome across the female life cycle,” Sleep Medicine, vol. 9, no. 7, pp. 799–802, 2008. View at Publisher · View at Google Scholar · View at Scopus
  91. B. S. McEwen, “Physiology and neurobiology of stress and adaptation: central role of the brain,” Physiological Reviews, vol. 87, no. 3, pp. 873–904, 2007. View at Publisher · View at Google Scholar · View at Scopus
  92. B. S. McEwen, “Sleep deprivation as a neurobiologic and physiologic stressor: allostasis and allostatic load,” Metabolism, vol. 55, supplement 1, pp. S20–S23, 2006. View at Publisher · View at Google Scholar · View at Scopus
  93. R. P. Brown and P. L. Gerbarg, “Sudarshan Kriya yogic breathing in the treatment of stress, anxiety, and depression: part I—neurophysiologic model,” Journal of Alternative and Complementary Medicine, vol. 11, no. 1, pp. 189–201, 2005. View at Publisher · View at Google Scholar · View at Scopus
  94. K. E. Innes, H. K. Vincent, and A. G. Taylor, “Chronic stress and insulin resistance-related indices of cardiovascular disease risk, part I: neurophysiological responses and pathological sequelae,” Alternative Therapies in Health and Medicine, vol. 13, no. 4, pp. 46–52, 2007. View at Scopus
  95. K. E. Innes, H. K. Vincent, and A. G. Taylor, “Chronic stress and insulin resistance-related indices of cardiovascular disease risk, part 2: a potential role for mind-body therapies,” Alternative Therapies in Health and Medicine, vol. 13, no. 5, pp. 44–51, 2007. View at Scopus
  96. D. L. Cohen, N. Wintering, V. Tolles et al., “Cerebral blood flow effects of yoga training: preliminary evaluation of 4 cases,” Journal of Alternative and Complementary Medicine, vol. 15, no. 1, pp. 9–14, 2009. View at Publisher · View at Google Scholar · View at Scopus
  97. C. C. Streeter, J. E. Jensen, R. M. Perlmutter et al., “Yoga Asana sessions increase brain GABA levels: a pilot study,” Journal of Alternative and Complementary Medicine, vol. 13, no. 4, pp. 419–426, 2007. View at Publisher · View at Google Scholar · View at Scopus
  98. T. W. Kjaer, C. Bertelsen, P. Piccini, D. Brooks, J. Alving, and H. C. Lou, “Increased dopamine tone during meditation-induced change of consciousness,” Cognitive Brain Research, vol. 13, no. 2, pp. 255–259, 2002. View at Publisher · View at Google Scholar · View at Scopus
  99. S. Leknes and I. Tracey, “A common neurobiology for pain and pleasure,” Nature Reviews Neuroscience, vol. 9, no. 4, pp. 314–320, 2008. View at Publisher · View at Google Scholar · View at Scopus
  100. E. Mignot, S. Taheri, and S. Nishino, “Sleeping with the hypothalamus: emerging therapeutic targets for sleep disorders,” Nature Neuroscience, vol. 5, pp. 1071–1075, 2002. View at Publisher · View at Google Scholar · View at Scopus
  101. I. K. Goerendt, C. Messa, A. D. Lawrence, P. M. Grasby, P. Piccini, and D. J. Brooks, “Dopamine release during sequential finger movements in health and Parkinson's disease: a PET study,” Brain, vol. 126, no. 2, pp. 312–325, 2003. View at Publisher · View at Google Scholar · View at Scopus
  102. R. Scranton and A. Cincotta, “Bromocriptine unique formulation of a dopamine agonist for the treatment of type 2 diabetes,” Expert Opinion on Pharmacotherapy, vol. 11, no. 2, pp. 269–279, 2010. View at Publisher · View at Google Scholar · View at Scopus
  103. J. M. Belavic, “A new treatment option for type 2 diabetes,” The Nurse Practitioner, vol. 35, no. 1, pp. 51–52, 2010.
  104. K. G. Lloyd and P. Worms, “Neuropharmacological actions of GABA agonists: predictability for their clinical usefulness,” Advances in Biochemical Psychopharmacology, vol. 29, pp. 59–67, 1981. View at Scopus
  105. I. S. Shiah and L. N. Yatham, “GABA function in mood disorders: an update and critical review,” Life Sciences, vol. 63, no. 15, pp. 1289–1303, 1998. View at Publisher · View at Google Scholar · View at Scopus
  106. S. J. Enna and K. E. McCarson, “The role of GABA in the mediation and perception of pain,” Advances in Pharmacology, vol. 54, pp. 1–27, 2006. View at Publisher · View at Google Scholar
  107. G. Chouinard, “The search for new off-label indications for antidepressant, antianxiety, antipsychotic and anticonvulsant drugs,” Journal of Psychiatry and Neuroscience, vol. 31, no. 3, pp. 168–176, 2006. View at Scopus
  108. L. M. Arnold, D. L. Goldenberg, S. B. Stanford et al., “Gabapentin in the treatment of fibromyalgia: a randomized, double-blind, placebo-controlled, multicenter trial,” Arthritis and Rheumatism, vol. 56, no. 4, pp. 1336–1344, 2007. View at Publisher · View at Google Scholar · View at Scopus
  109. J. K. Baillie and I. Power, “The mechanism of action of gabapentin in neuropathic pain,” Current Opinion in Investigational Drugs, vol. 7, no. 1, pp. 33–39, 2006. View at Scopus
  110. S. Fulda and T. C. Wetter, “Where dopamine meets opioids: a meta-analysis of the placebo effect in restless legs syndrome treatment studies,” Brain, vol. 131, part 4, pp. 902–917, 2008. View at Publisher · View at Google Scholar · View at Scopus
  111. H. Benes, A. S. Walters, R. P. Allen, W. A. Hening, and R. Kohnen, “Definition of restless legs syndrome, how to diagnose it, and how to differentiate it from RLS mimics,” Movement Disorders, vol. 22, supplement 18, pp. S401–S408, 2007. View at Publisher · View at Google Scholar · View at Scopus
  112. F. Brindani, F. Vitetta, and F. Gemignani, “Restless legs syndrome: differential diagnosis and management with pramipexole,” Clinical Interventions in Aging, vol. 4, pp. 305–313, 2009. View at Scopus
  113. R. A. Hansen, L. Song, C. G. Moore et al., “Effect of ropinirole on sleep outcomes in patients with restless legs syndrome: meta-Analysis of pooled individual patient data from randomized controlled trials,” Pharmacotherapy, vol. 29, no. 3, pp. 255–262, 2009. View at Publisher · View at Google Scholar · View at Scopus
  114. C. F. Conti, M. M. De Oliveira, R. B. Andriolo et al., “Levodopa for idiopathic restless legs syndrome: evidence-based review,” Movement Disorders, vol. 22, no. 13, pp. 1943–1951, 2007. View at Publisher · View at Google Scholar · View at Scopus
  115. C. F. Conti, M. M. De Oliveira, J. S. Valbuza, L. B. F. Prado, L. B. C. De Carvalho, and G. F. D. Prado, “Anticonvulsants to treat idiopathic restless legs syndrome: systematic review,” Arquivos de Neuro-Psiquiatria, vol. 66, no. 2, pp. 431–435, 2008. View at Publisher · View at Google Scholar · View at Scopus
  116. C. A. Kushida, “Ropinirole for the treatment of restless legs syndrome,” Neuropsychiatric Disease and Treatment, vol. 2, no. 4, pp. 407–419, 2006. View at Publisher · View at Google Scholar · View at Scopus
  117. J. W. Winkelman, S. Redline, C. M. Baldwin, H. E. Resnick, A. B. Newman, and D. J. Gottlieb, “Polysomnographic and health-related quality of life correlates of restless legs syndrome in the sleep heart health study,” Sleep, vol. 32, no. 6, pp. 772–778, 2009. View at Scopus
  118. M. Hornyak, M. Kopasz, M. Berger, D. Riemann, and U. Voderholzer, “Impact of sleep-related complaints on depressive symptoms in patients with restless legs syndrome,” Journal of Clinical Psychiatry, vol. 66, no. 9, pp. 1139–1145, 2005. View at Scopus
  119. W. Hening, A. S. Walters, R. P. Allen, J. Montplaisir, A. Myers, and L. Ferini-Strambi, “Impact, diagnosis and treatment of restless legs syndrome (RLS) in a primary care population: the REST (RLS epidemiology, symptoms, and treatment) primary care study,” Sleep Medicine, vol. 5, no. 3, pp. 237–246, 2004. View at Publisher · View at Google Scholar · View at Scopus